Ignite Creation Date:
2024-05-11 @ 8:31 AM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06401551
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-20
First Post:
2024-05-02
Brief Title:
Clareon PanOptix Pro vs Clareon PanOptix - Study B
Sponsor:
Alcon Research
Organization:
Alcon Research
Study Overview
Official Title:
Contralateral Study of Clareon PanOptix Pro vs Clareon PanOptix
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the safety and effectiveness of Clareon PanOptix Pro Trifocal Intraocular Lens IOL compared to Clareon PanOptix Trifocal IOL
Detailed Description:
Subjects will attend 9 scheduled study visits for a total individual duration of participation of approximately 7 months The primary endpoint will be assessed at the Month 2 follow-up visit Both eyes of a subject must qualify for enrollment into this study
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
True
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None